Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway.

Por Stancato, L F, Sakatsume, M, David, M, Dent, P, Dong, F, Petricoin, E F, Krolewski, J J, Silvennoinen, O, Saharinen, P, Pierce, J, Marshall, C J, Sturgill, T, Finbloom, D S, Larner, A C
Publicado em 1997

Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F

Por Ma, L, Clayton, J R, Walgren, R A, Zhao, B, Evans, R J, Smith, M C, Heinz-Taheny, K M, Kreklau, E L, Bloem, L, Pitou, C, Shen, W, Strelow, J M, Halstead, C, Rempala, M E, Parthasarathy, S, Gillig, J R, Heinz, L J, Pei, H, Wang, Y, Stancato, L F, Dowless, M S, Iversen, P W, Burkholder, T P
Publicado em 2013